Quantro Therapeutics GMBH

quantro therapeutics (“quantro”) is a research-based entity that strives to discover and develop novel therapeutics interfering with disease-causing transcriptional programs in cancer and other diseases. quantro will assemble a highly innovative drug-discovery pipeline that employs time-resolved rna sequencing and comparative transcriptomics to identify and develop drug candidates interfering with transcriptional regulators. the first focus will be on cancer-associated transcription factors, which so far have been unamenable to pharmacologic intervention. quantro was founded as a spin-off of the institute of molecular biotechnology (“imba”) and the research institute of molecular pathology (“imp”), both located in vienna, austria.